Angola vs Guinea-Bissau: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Guinea-Bissau
2.7%
in 2024
Angola rank
5th
Guinea-Bissau rank
9th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Guinea-Bissau
How they compare
Angola currently reports 3.1% against 2.7% in Guinea-Bissau, a difference of 0.4%.
That makes Angola's figure about 1.1 times Guinea-Bissau's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Guinea-Bissau ahead.
Angola ranks 5th and Guinea-Bissau ranks 9th of 246 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Angola | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 2.8% | 0.2% | Guinea-Bissau |
| 2020s | 3.0% | 2.7% | 0.3% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Guinea-Bissau?
- Angola, at 3.1% against 2.7% in Guinea-Bissau as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Guinea-Bissau?
- 0.4%, with Angola ahead.
- How many years of comparable data are there for Angola and Guinea-Bissau?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Guinea-Bissau rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Guinea-Bissau ranks 9th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.